Today: 30 April 2026
Unilever stock rebounds in London as Jefferies warns on margins, India tax order watched
9 January 2026
1 min read

Unilever stock rebounds in London as Jefferies warns on margins, India tax order watched

London, Jan 9, 2026, 10:48 GMT — Regular session

  • Unilever shares rose about 1.2% in early London trade after a volatile week
  • Jefferies stuck with an “underperform” view, flagging margin and pricing pressure risks
  • The group’s India arm said it will appeal a 15.6 billion-rupee tax demand

Unilever shares rose 1.2% to 4,720.5 pence by 1033 GMT, bouncing from an early low of 4,678 pence as investors weighed fresh broker caution against a steady stream of company updates. The stock has traded between 4,123 and 4,930 pence over the past 52 weeks.

Why it matters now: Unilever heads into a key reporting stretch with the market fixated on whether growth in 2026 comes from higher volumes, not just price rises. Broker notes and small regulatory filings have started to move the shares again, even when the underlying news is not decisive.

Jefferies reiterated an “underperform” rating and lifted its target price to 4,100 pence, updating its estimates after Unilever’s ice cream spin-off. Analyst David Hayes said he still saw “downside risk” to valuation, pointing to pricing and operating margin pressures; Jefferies expects “volume-mix” (a measure of how many units sell and what mix of products customers buy) to improve by about 2% in the fourth quarter and like-for-like sales growth (which strips out currency swings and acquisitions) to land between 4% and 6% for the year. sharecast.com

In India, Hindustan Unilever said it received a tax demand order for 15.6 billion rupees ($173.6 million) and plans to appeal, adding it expects no material impact on its financials or operations. The update drew attention because India remains a key market for global consumer groups, and tax disputes can linger.

Separately, a Unilever filing corrected an earlier “total voting rights” disclosure, a share-count figure investors use to calculate when they must notify regulators about changes in their stakes. The company said its issued share capital stood at 2,181,005,247 ordinary shares and that 2,180,690,335 shares carried exercisable voting rights at year-end after correcting an error in a prior announcement. Investegate

Analyst sentiment stayed mixed. BNP Paribas Exane downgraded Unilever’s U.S.-listed shares to “neutral” from “outperform” and set a $71 price target, according to a MarketBeat report summarising the note. MarketBeat

But the upside case still hinges on execution. A tougher pricing backdrop, any wobble in operating margins, or a slower pace of volume recovery could pull the shares back toward this week’s lows, especially if investors decide the stock’s valuation leaves less room for disappointment.

Next up, investors will focus on Unilever’s fourth-quarter and full-year 2025 results on Feb. 12, followed by its appearance at the CAGNY conference on Feb. 17, for signals on 2026 growth, margins and how demand is holding up across categories.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom
Previous Story

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

UK stock market today: FTSE100 rises as Glencore jumps on Rio takeover talks
Next Story

UK stock market today: FTSE100 rises as Glencore jumps on Rio takeover talks

Go toTop